Background The prevention and early diagnosis of gastric cancer permit clinicians to discover the tumor in the initial phase, during which time it can be completely eradicated, endoscopically or surgically. Since Murakami gave the definition of early gastric cancer (EGC) in 1971, many authors have identified various subtypes of EGC with different morphological characteristics and clinical behaviour. Methods We evaluated retrospectively 530 patients: the median follow-up time was 10.4 months (range 0.3-29.2). All tumors were classified according to the macroscopic and microscopic criteria proposed by the Japanese Society of Gastroenterology and Endoscopy and Lauren, respectively. The infiltrative growth pattern was evaluated according to Kodama's classification. Only tumor-related death was considered as an endpoint of interest for the survival analysis.
Introduction
The term ''early gastric cancer'' (EGC), defined in 1971 by the Japanese Society of Gastroenterology and Endoscopy [1] as carcinoma limited to gastric mucosa and or submucosa regardless of lymph node status, has continued to spark controversies over the years [2] [3] [4] .
Numerous studies have focused on key parameters that could be associated with the risk of lymph node metastases or treatment failure in EGC [3] [4] [5] [6] [7] .
Better knowledge and increased numbers of EGC have resulted from the improvement and diffusion of endoscopies and the introduction of new technologies, such as chromoendoscopy and magnifying endoscopy.
In our area, which has a high incidence of gastric cancer, EGC represents about 25 % of all gastric cancers treated surgically. This percentage of ''early lesions'' is considered to be really good for Western countries, even though not yet comparable to those of Eastern countries, where EGCs represent more than 50 % of all tumors [8] . The presence of an active mass screening program [9] and different classification systems for gastrointestinal dysplasia and gastric carcinoma in Eastern and Western countries [10] [11] [12] [13] [14] [15] [16] still accounts for significant differences in the detection of EGC.
In particular, the experience we gained by evaluating 530 patients affected by EGC has demonstrated that there is a significantly worse survival probability in node-positive and PEN A type patients, as we suggested in our previous reports [5] [6] [7] .
According to Kodama's classification, the abbreviation PEN stands for penetrating and indicates a lesion with a diameter of less than 4 cm that invades the submucosa in a widely penetrating fashion. In particular, PEN A type EGC represents a subgroup of tumors that invades the submucosa extensively, with nodular masses, causing the complete destruction of the muscularis mucosae.
We were also able to demonstrate the important clinical impact of size, depth of infiltration, and histological type of tumors, with special reference to the distribution of lymph node metastases.
According to our data, which identified subgroups of patients with a different prognosis, we propose to introduce a revised definition of EGC, considering as ''early'' only those tumors limited to the mucosal layer or, at least, minimally invading submucosa, considering minimally invading the EGCs with a depth of submucosal infiltration less than 500 lm (SM1 tumors), and without lymph node metastases. Such a consideration is prompted, not only by the prognostic behaviour of the different kinds of tumors, but also by the possibility of identifying the patients who can be safely and radically treated with endoscopic resection, defined by evaluation of the endoscopic specimen, according to Japanese guidelines.
Subjects and methods
We analyzed retrospectively the data from 530 patients who underwent surgery at G.B. Morgagni-L. Pierantoni Hospital of Forlì (Italy) between 1976 and 2006. The EGC/ advanced cancer ratio was 25 %.
All the patients underwent a subtotal or total gastrectomy with a D2 lymphadenectomy, according to Japanese guidelines. The EGCs were classified according to macroscopic and microscopic criteria proposed by the Japanese Society of Gastroenterology and Endoscopy (JSGE) and Lauren, respectively [17, 18] . The JSGE criteria divided the EGCs into type I (polypoid), type IIa (elevated), type IIb (flat), type IIc (depressed), and type III (excavated). From the histological point of view, two main categories exist, designated as intestinal and diffuse by Lauren. A third group includes mixed carcinomas. The classification of Kodama [19] was used to define the extent and histological growth pattern of penetration of the cancer (Table 1 ). According to this classification, the super (superficial spreading) type is a tumor with a diameter of more than 4 cm, either confined to the mucosa (Super M) or with minimal invasion of the submucosa (Super SM); small mucosal type is a carcinoma with a diameter of less than 4 cm, with (small mucosal SM) or without (small mucosal M) a minimal submucosal invasion; and PEN (penetrating) type is a lesion with a diameter of less than 4 cm, which invades the submucosa widely. This type is further subdivided into two subgroups, according to the type of infiltration of the muscularis mucosae: PEN A type, which invades the submucosa extensively with nodular masses and completely destroys the muscularis mucosae, and PEN B type, which grows infiltratively, with fenestration of the muscularis mucosae. The resected stomachs were opened along the greater curvature, pinned to a wooden plate, and fixed in 10 % buffered formalin. The tumors in the surrounding gastric wall were cut into several slices, mainly parallel to the lesser curvature, at intervals of 4-5 mm. Sections 5 lm thick, embedded in paraffin, were prepared from each slide for histological examination. The WHO classification was used to define the degree of tumor differentiation [20] . Lymph nodes were completely included in paraffin blocks from which two different microtomic levels at a distance of 200 lm were cut. A maximum number of five lymph nodes was included in each paraffin block. Then, two slides including slices of the lymph nodes cut at the two different levels obtained from each paraffin block were stained. The median follow-up was 10.4 months (range, 0.3-29.2 months). Overall survival (OS) was calculated as the period from the date of surgical treatment until death.
Only tumor-related deaths were considered as an endpoint of interest for the survival analysis.
Five-and 10-year OS probability and the 95 % confidence interval (95 % CI) were obtained using KaplanMeier estimates [21] . The null hypothesis concerning the different impact of each variable on clinical outcome was tested in univariate analysis by a log-rank test [22] .
The prognostic effect of each variable was evaluated in univariate and multivariate analyses using a Cox regression model [23] .
The chi-square test was employed to define the association between the subgroups of pathological and clinical criteria examined.
All p values were based on two-sided testing, and statistical analyses were carried out using SAS statistical software [24] .
Results
Among our patients, 305 were men and 225 women. About 50 % of the EGCs were located in the lower third of the stomach. We missed some topographic data, especially in the oldest cases. Almost all cases were monofocal (94.3 %). Intramucosal and submucosal infiltration were observed with similar frequency. Macroscopic IIc and III types were found in more than 70 % of all tumors; small mucosal M Kodama's type represented about 50 % of all lesions (Table 1) . Histologically, the intestinal type was the most frequent finding (78.7 %), according to Lauren's classification. Lymph node metastases affected 78 patients (14.7 %).
The lymph node status was significantly associated with histological type (p \ 0.0001), infiltration of the wall (p \ 0.0001), tumor size (p = 0.0004), and Kodama's type (p \ 0.0001). In particular, the incidence of lymph node metastases was 31.7 % for Kodama's PEN A types, 30.2 % for histological diffuse types, 25.8 % for submucosal lesions, and 20.8 % for tumors larger than 2 cm (Table 2) . On univariate analysis, a significantly lower survival rate was observed for patients with submucosal tumours (p = 0.0006), PEN A type disease (p \ 0.0001), and nodepositive cancers (p = 0.0002) ( Table 3 ). In particular, a significantly worse prognosis was demonstrated for patients with more than three metastatic lymph nodes (p \ 0.0001). We have no information regarding a few older tumors.
Moreover, on multivariate analysis (Table 4) , EGC patients with more than three positive nodes had a risk of death about 13 times higher than that of patients with negative lymph nodes (HR, 12.78; 95 % CI, 5.37-30.43; p \ 0.0001), and EGC PEN A type patients had a 4-fold-higher death risk (HR, 3.91; 95 % CI, 2.08-7.33; p \ 0.0001).
No significantly worse prognosis was observed for patients affected by Kodama's types other than PEN A (Table 5) .
These results suggest that the biological behavior of EGCs depends tightly on the lymph node status and histological growth pattern according to Kodama's criteria. So, the patients with these findings must be considered affected by an advanced gastric cancer, instead of by an ''early lesion,'' and then considered for standard surgical treatment.
Among the 78 node-positive patients, 57 were affected by submucosal tumors and only 20 by intramucosal EGCs. One patient was lost from follow-up. Among the 20 intramucosal tumors, 11 lesions had a diameter of less than 2 cm and 9 measured more than 2 cm. Only 2 of the 11 smaller EGCs were well-differentiated tumors (grade 1 according to WHO classification), and both were ulcerated. 
Discussion
The improvement and diffusion of endoscopic techniques and better knowledge of the problem have led to a significant increase in early gastric cancers (EGC) over the past few years. In the Forlì area, EGC represents about 25 % of all resected gastric cancers [5, 6] . Now, our experience with EGC allows the endoscopic treatment of some of these tumors, when EGC characteristics exclude lymph node involvement. In particular, according to our results, Kodama's PEN A types, histological diffuse, submucosal tumors, and lesions larger than 2 cm are all conditions with a higher risk of lymph node metastases. All these aspects must be confirmed by pathologists after the endoscopic dissection. In fact, endoscopic mucosal resection (EMR)/ endoscopic submucosal resection (ESD) has a diagnostic value as its primary endpoint. Then, if none of the aforementioned unfavorable histological characteristics is detected, the endoscopic resection can be considered the definitive and safe treatment of the tumor, as some authors previously demonstrated [25] [26] [27] . Endoscopic resection of early gastric cancers with no risk of lymph node metastases is a standard technique in Japan, probably because of the high incidence of gastric cancer and the fact that more than half of Japanese gastric neoplasms are diagnosed at an early stage. This finding is also the result of the existence of different classification systems for gastrointestinal dysplasia and gastric carcinoma in Western and Eastern countries [10] [11] [12] [13] [14] [15] [16] . Recently endoscopic mucosal resection (EMR) has been increasingly accepted and regularly used in Western countries. Despite this, however, so far a wide European experience that could give us significant and useful information to be clinically applied and then compared to the data of Japanese authors has not been recorded. The latter have defined the criteria that must be evaluated by pathologists on the endoscopic specimen to consider EMR safe and radical as a treatment of EGC [28] [29] [30] [31] [32] [33] [34] . These criteria have been changed in the past 10 years, also because of the introduction of the new endoscopic techniques, such as endoscopic submucosal resection (ESD), which allows Japanese endoscopists to remove radically bigger lesions [25, [35] [36] [37] [38] . Tumor conditions suitable only for endoscopic resection as a treatment of choice to remove the lesions completely [25, 31] are neoplasias less than 2 cm, histologically well differentiated, limited to the mucosa, and without ulcer and lymphatic/ vessel invasion. When these conditions are all met, the endoscopic treatment of the tumors can be considered safe.
On the other hand, if only one of the unfavorable parameters occurs, the patient must be treated surgically because of the significant risk of lymph node metastases. This consideration is true also in our series: among the 78 nodepositive patients there were 20 intramucosal EGCs, each of which showed at least one of the unfavorable histological parameters. The retrospective analysis of our series of EGCs showed that tumor size larger than 2 cm (66.7 %), infiltration of the submucosa (74.0 %), diffuse histological type (29.2 %), and Kodama's PEN A type (42.3 %) were important and significant risk factors for lymph node metastases. Moreover, univariate analysis demonstrated that patients with submucosal lesions (89 % at 5 years and 83 % at 10 years), Kodama's PEN A type cancers (83 % at 5 years and 73 % at 10 years), lymph node metastases (82 % at 5 years and 78 % at 10 years) and more than three positive lymph nodes (53 % at 5 years and 46 % at 10 years) had a significantly worse prognosis.
This knowledge permitted us to identify subgroups of EGC patients affected by different stages of the disease, strictly linked to clinical behavior, prognosis, and then the treatment. The depth of wall invasion has been considered the most important prognostic factor since Murakami introduced the definition of early gastric cancer in 1971.
Subsequent clinical evidence, however, has consistently indicated nodal involvement as the most important prognostic parameter, so that only cancers without nodal invasion were considered as early neoplasms [39, 40] . By taking this into consideration, some authors have demonstrated that the disease in patients with gastric cancer without lymph node metastases, but with invasion of the muscularis propria, behaved in a similar way to the disease in conventional EGC patients [41] .
We previously demonstrated that both the invasion of submucosa and the presence of lymph node metastases must be considered unfavorable prognostic factors in EGC patients, suggesting modification of the definition of EGC [5, 6] .
Apart from our previous observations, few reports have suggested upgrading the definition of EGC by identifying subgroups of patients with nodal metastases, characterized by a worse prognosis [3, 39, 40] . According to these authors, infiltration into the wall was not so important as lymph node status for establishing the biological behavior and prognosis of the tumor. Again, in our current larger series, we have shown that lymph node metastases and Kodama's PEN A type still remain independent prognostic factors; moreover, the massive infiltration of the submucosa in EGC patients means a higher risk of lymph node metastases. For this reason, we propose to reconsider the definition of EGC as Murakami conceived it in 1971. According to our experience, it should be more appropriate to call ''early'' those gastric cancers that are limited to the mucosa, or at least do not infiltrate the submucosal layer massively, and have no lymph node metastases.
